Furthermore, glutamate concentrations are reduced in frontal areas in experimental and clinical pain (Thompson and Neugebauer, 2019), and a frontal glutamatergic dysfunction has been implicated in depression as well (Moriguchi et al., 2019)
ST depression, etc.) CNS : nausea, vomiting, fatigue, anorexia , dizziness, dreams, psychic complaints, headache), visual disturbances (
Uric acid therapy prevents early ischemic stroke progression: a Tertiary analysis of the URICO-ICTUS trial (Efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke)
Half-Life: It has a long half-life, which means it remains active in the body for an extended period, allowing for less frequent dosing